HOXC13 is significantly up-regulated in ESCC in association with poorer clinic-pathological features and worse prognosis of the patients, and its knockdown decreases cell proliferation and induces apoptosis in ESCC cells [147]. Here, HOXC13 is linked to esophageal squamous cell carcinoma.